Find all needed information about Percutaneous Circulatory Support In Cardiogenic Shock. Below you can see links where you can find everything you want to know about Percutaneous Circulatory Support In Cardiogenic Shock.
https://www.ahajournals.org/doi/full/10.1161/circulationaha.111.040220
In the Impella LP2.5 vs. IABP in Cardiogenic SHOCK (ISAR-SHOCK) trial, patients with LV failure after AMI who received circulatory support with the Impella Recover 2.5 PVAD had significant improvement in cardiac index after 30 minutes of support compared with patients supported by IABP.Cited by: 85
https://www.ncbi.nlm.nih.gov/pubmed/28857849
Advanced Percutaneous Mechanical Circulatory Support Devices for Cardiogenic Shock. Miller PE(1), Solomon MA, McAreavey D. Author information: (1)1Critical Care Medicine, National Institutes of Health Clinical Center, Bethesda, MD. 2Cardiovascular and Pulmonary Branch, National Heart, Lung, and Blood Institute, Bethesda, MD.Cited by: 13
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408785/
Mar 09, 2019 · Mechanical circulatory support is an essential part of the management of cardiogenic shock and is commonly utilized as a bridge-to-decision, whether it is recovery, palliation, heart transplant or a durable mechanical circulatory support device.Cited by: 7
https://www.sciencedirect.com/science/article/pii/S0735109716367675
Jan 24, 2017 · The IMPRESS in Severe Shock (IMPella versus IABP Reduces mortality in STEMI patients treated with primary PCI in Severe cardiogenic SHOCK) trial is an exploratory assessment of mortality and other safety outcomes comparing percutaneous mechanical circulatory support (pMCS) by the Impella CP with IABP in mechanically ventilated patients with CS ...Cited by: 250
https://www.acc.org/latest-in-cardiology/ten-points-to-remember/2017/07/20/15/10/percutaneous-short-term-active-mechanical-support-devices
Jul 20, 2017 · The following are key points to remember from this review on percutaneous short-term active mechanical circulatory support (MCS) devices in patients with cardiogenic shock (CS): Evidence on the impact on clinical outcome of active MCS devices in CS is scarce.
http://www.onlinejacc.org/content/69/3/278
Jan 24, 2017 · Background Despite advances in treatment, mortality in acute myocardial infarction (AMI) complicated by cardiogenic shock (CS) remains high. Short-term mechanical circulatory support devices acutely improve hemodynamic conditions. Objectives The aim of this study was to determine whether a new percutaneous mechanical circulatory support (pMCS) device (Impella CP, …Cited by: 250
https://ccforum.biomedcentral.com/articles/10.1186/s13054-019-2368-y
Oct 31, 2018 · Mechanical circulatory support is an essential part of the management of cardiogenic shock and is commonly utilized as a bridge-to-decision, whether it is recovery, palliation, heart transplant or a durable mechanical circulatory support device.Cited by: 7
Need to find Percutaneous Circulatory Support In Cardiogenic Shock information?
To find needed information please read the text beloow. If you need to know more you can click on the links to visit sites with more detailed data.
